Price
$21.82
Increased by +0.69%
Dollar volume (20D)
2.53 M
ADR%
5.25
Earnings report date
Apr 28, 2026
Shares float
9.54 M
Shares short
481.81 K [5.05%]
Shares outstanding
18.28 M
Market cap
396.15 M
Beta
0.64
Price/earnings
24.08
20D range
18.57 22.59
50D range
18.57 22.90
200D range
18.48 38.32

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

It operates in two segments, Direct selling and Hiya Direct-To-Consumer.

The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration.

It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online.

The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.

USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Reported date EPSChange YoY EstimateSurprise
Feb 17, 26 0.60
Decreased by -6.25%
0.40
Increased by +50.00%
Nov 5, 25 -0.36
Decreased by -164.29%
0.56
Decreased by -164.29%
Jul 21, 25 0.74
Increased by +37.04%
0.54
Increased by +37.04%
Apr 28, 25 0.73
Decreased by -15.12%
0.70
Increased by +4.29%
Feb 4, 25 0.64
Decreased by -26.44%
0.49
Increased by +30.61%
Oct 22, 24 0.56
Decreased by -5.08%
0.49
Increased by +14.29%
Jul 23, 24 0.54
Decreased by -39.33%
0.65
Decreased by -16.92%
Apr 30, 24 0.86
Decreased by -9.47%
0.69
Increased by +24.64%
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 25 226.20 M
Increased by +5.89%
-1.77 M
Decreased by -139.59%
Decreased by -0.78%
Decreased by -137.38%
Sep 30, 25 213.67 M
Increased by +6.72%
-6.52 M
Decreased by -161.49%
Decreased by -3.05%
Decreased by -157.62%
Jun 30, 25 235.85 M
Increased by +10.79%
9.65 M
Decreased by -7.45%
Increased by +4.09%
Decreased by -16.47%
Mar 31, 25 249.54 M
Increased by +9.54%
9.40 M
Decreased by -43.15%
Increased by +3.77%
Decreased by -48.10%
Dec 31, 24 213.61 M
Decreased by -3.38%
4.48 M
Decreased by -73.26%
Increased by +2.10%
Decreased by -72.32%
Sep 30, 24 200.22 M
Decreased by -6.16%
10.61 M
Decreased by -6.52%
Increased by +5.30%
Decreased by -0.38%
Jun 30, 24 212.87 M
Decreased by -10.64%
10.43 M
Decreased by -39.67%
Increased by +4.90%
Decreased by -32.49%
Mar 31, 24 227.80 M
Decreased by -8.28%
16.54 M
Decreased by -10.04%
Increased by +7.26%
Decreased by -1.92%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY